{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T19:38:44Z","timestamp":1793993924979,"version":"4.8.0"},"reference-count":136,"publisher":"Impact Journals, LLC","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2020,5,1]]},"DOI":"10.18632\/aging.103095","type":"journal-article","created":{"date-parts":[[2020,5,2]],"date-time":"2020-05-02T14:35:52Z","timestamp":1588430152000},"page":"8742-8759","source":"Crossref","is-referenced-by-count":46,"title":["Metformin: the updated protective property in kidney disease"],"prefix":"10.18632","volume":"12","author":[{"given":"Qingjun","family":"Pan","sequence":"first","affiliation":[{"name":"Key Laboratory of Prevention and Management of Chronic Kidney Disease of Zhanjiang, Institute of Nephrology, Affiliated Hospital of Guangdong Medical University, Zhanjiang 524001, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Lu","sequence":"additional","affiliation":[{"name":"Key Laboratory of Prevention and Management of Chronic Kidney Disease of Zhanjiang, Institute of Nephrology, Affiliated Hospital of Guangdong Medical University, Zhanjiang 524001, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunfei","family":"Zhao","sequence":"additional","affiliation":[{"name":"Key Laboratory of Prevention and Management of Chronic Kidney Disease of Zhanjiang, Institute of Nephrology, Affiliated Hospital of Guangdong Medical University, Zhanjiang 524001, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuzhen","family":"Liao","sequence":"additional","affiliation":[{"name":"Key Laboratory of Prevention and Management of Chronic Kidney Disease of Zhanjiang, Institute of Nephrology, Affiliated Hospital of Guangdong Medical University, Zhanjiang 524001, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqun","family":"Chen","sequence":"additional","affiliation":[{"name":"Key Laboratory of Prevention and Management of Chronic Kidney Disease of Zhanjiang, Institute of Nephrology, Affiliated Hospital of Guangdong Medical University, Zhanjiang 524001, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengbiao","family":"Guo","sequence":"additional","affiliation":[{"name":"Key Laboratory of Prevention and Management of Chronic Kidney Disease of Zhanjiang, Institute of Nephrology, Affiliated Hospital of Guangdong Medical University, Zhanjiang 524001, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Yang","sequence":"additional","affiliation":[{"name":"Key Laboratory of Prevention and Management of Chronic Kidney Disease of Zhanjiang, Institute of Nephrology, Affiliated Hospital of Guangdong Medical University, Zhanjiang 524001, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua-feng","family":"Liu","sequence":"additional","affiliation":[{"name":"Key Laboratory of Prevention and Management of Chronic Kidney Disease of Zhanjiang, Institute of Nephrology, Affiliated Hospital of Guangdong Medical University, Zhanjiang 524001, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2020,5,1]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"A7","DOI":"10.1053\/j.ajkd.2019.01.001","article-title":"US Renal Data System 2018 Annual Data Report: Epidemiology of Kidney Disease in the United States.","volume":"7","author":"Gipson","year":"2019","journal-title":"Am J Kidney Dis"},{"key":"2","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/S2213-8587(19)30002-6","article-title":"Use of metformin to treat pregnant women with polycystic ovary syndrome (PregMet2): a randomised, double-blind, placebo-controlled trial.","volume":"7","author":"Hjelle","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"3","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.ccell.2019.03.007","article-title":"Combination of Hypoglycemia and Metformin Impairs Tumor Metabolic Plasticity and Growth by Modulating the PP2A-GSK3\u03b2-MCL-1 Axis.","volume":"3","author":"Janssens","year":"2019","journal-title":"Cancer Cell"},{"key":"4","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1146\/annurev-med-081117-041238","article-title":"Metformin for Treatment of Fragile X Syndrome and Other Neurological Disorders.","volume":"7","author":"Sonenberg","year":"2019","journal-title":"Annu Rev Med"},{"key":"5","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3390\/ijms20010042","article-title":"Metformin: A Candidate Drug for Renal Diseases.","volume":"2","author":"Verhulst","year":"2018","journal-title":"Int J Mol Sci"},{"key":"6","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s12882-017-0579-5","article-title":"Risk of acute kidney injury and survival in patients treated with Metformin: an observational cohort study.","volume":"1","author":"Looker","year":"2017","journal-title":"BMC Nephrol"},{"key":"7","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.kint.2018.01.027","article-title":"Metformin prevents the development of severe chronic kidney disease and its associated mineral and bone disorder.","volume":"9","author":"D\u2019Haese","year":"2018","journal-title":"Kidney Int"},{"key":"8","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1002\/jcp.25598","article-title":"Nephroprotective Effects of Metformin in Diabetic Nephropathy.","volume":"23","author":"Munusamy","year":"2017","journal-title":"J Cell Physiol"},{"key":"9","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1159\/000488807","article-title":"A Randomized Clinical Trial of Metformin to Treat Autosomal Dominant Polycystic Kidney Disease.","volume":"4","author":"Bae","year":"2018","journal-title":"Am J Nephrol"},{"key":"10","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3390\/cells8040323","article-title":"The Potential Use of Metformin, Dipyridamole, N-Acetylcysteine and Statins as Adjunctive Therapy for Systemic Lupus Erythematosus.","volume":"8","author":"Mak","year":"2019","journal-title":"Cells"},{"key":"11","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ejca.2015.09.027","article-title":"Use of metformin and risk of kidney cancer in patients with type 2 diabetes.","volume":"5","author":"Tseng","year":"2016","journal-title":"Eur J Cancer"},{"key":"12","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1159\/000370034","article-title":"Metformin use in kidney transplant recipients in the United States: an observational study.","volume":"4","author":"Israni","year":"2014","journal-title":"Am J Nephrol"},{"key":"13","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.cmet.2014.09.013","article-title":"AMPK\u2014sensing energy while talking to other signaling pathways.","volume":"2","author":"Hardie","year":"2014","journal-title":"Cell Metab"},{"key":"14","doi-asserted-by":"publisher","first-page":"40544","DOI":"10.1038\/srep40544","article-title":"Sustained kidney biochemical derangement in treated experimental diabetes: a clue to metabolic memory.","volume":"7","author":"de M Loureiro","year":"2017","journal-title":"Sci Rep"},{"key":"15","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1681\/ASN.2011010026","article-title":"AMPK mediates the initiation of kidney disease induced by a high-fat diet.","volume":"2","author":"Sharma","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"16","doi-asserted-by":"publisher","first-page":"315494","DOI":"10.1155\/2014\/315494","article-title":"Role of nutrient-sensing signals in the pathogenesis of diabetic nephropathy.","volume":"201","author":"Maegawa","year":"2014","journal-title":"Biomed Res Int"},{"key":"17","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.biopha.2018.07.085","article-title":"A preclinical overview of metformin for the treatment of type 2 diabetes.","volume":"10","author":"Wang","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"18","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.2967\/jnumed.116.177774","article-title":"In Vivo Imaging of Human 11C-Metformin in Peripheral Organs: Dosimetry, Biodistribution, and Kinetic Analyses.","volume":"5","author":"Jessen","year":"2016","journal-title":"J Nucl Med"},{"key":"19","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.cmet.2014.09.018","article-title":"Metformin: from mechanisms of action to therapies.","volume":"2","author":"Viollet","year":"2014","journal-title":"Cell Metab"},{"key":"20","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1007\/s00125-017-4335-y","article-title":"The pharmacogenetics of metformin.","volume":"6","author":"Florez","year":"2017","journal-title":"Diabetologia"},{"key":"21","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1161\/CIRCULATIONAHA.107.744490","article-title":"Phosphorylation of LKB1 at serine 428 by protein kinase C-zeta is required for metformin-enhanced activation of the AMP-activated protein kinase in endothelial cells.","volume":"11","author":"Zou","year":"2008","journal-title":"Circulation"},{"key":"22","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.1007\/s00125-011-2311-5","article-title":"Metformin activates AMP-activated protein kinase in primary human hepatocytes by decreasing cellular energy status.","volume":"5","author":"Guigas","year":"2011","journal-title":"Diabetologia"},{"key":"23","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1007\/s00125-017-4342-z","article-title":"The mechanisms of action of metformin.","volume":"6","author":"Pearson","year":"2017","journal-title":"Diabetologia"},{"key":"24","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.4161\/auto.19821","article-title":"Emerging role of autophagy in kidney function, diseases and aging.","volume":"8","author":"Dong","year":"2012","journal-title":"Autophagy"},{"key":"25","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3390\/cells8010061","article-title":"Autophagy in Chronic Kidney Diseases.","volume":"8","author":"Wang","year":"2019","journal-title":"Cells"},{"key":"26","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/ki.2013.559","article-title":"Rictor\/mTORC2 protects against cisplatin-induced tubular cell death and acute kidney injury.","volume":"8","author":"Dai","year":"2014","journal-title":"Kidney Int"},{"key":"27","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1159\/000368932","article-title":"Beneficial Effects of AMP-Activated Protein Kinase Agonists in Kidney Ischemia-Reperfusion: Autophagy and Cellular Stress Markers.","volume":"12","author":"Satriano","year":"2014","journal-title":"Nephron, Exp Nephrol"},{"key":"28","doi-asserted-by":"publisher","first-page":"23975","DOI":"10.1038\/srep23975","article-title":"Metformin Protects Against Cisplatin-Induced Tubular Cell Apoptosis and Acute Kidney Injury via AMPK\u03b1-regulated Autophagy Induction.","volume":"6","author":"Dai","year":"2016","journal-title":"Sci Rep"},{"key":"29","doi-asserted-by":"publisher","first-page":"7161","DOI":"10.1038\/s41598-017-07300-x","article-title":"Metformin Inhibits Cyst Formation in a Zebrafish Model of Polycystin-2 Deficiency.","volume":"7","author":"Cheng","year":"2017","journal-title":"Sci Rep"},{"key":"30","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s00005-017-0496-0","article-title":"Oxidative Stress in Kidney Diseases: The Cause or the Consequence?","volume":"6","author":"Mucha","year":"2018","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"31","doi-asserted-by":"publisher","first-page":"101","DOI":"10.4161\/oxim.3.2.11148","article-title":"Advanced glycation end products, oxidative stress and diabetic nephropathy.","volume":"3","author":"Matsui","year":"2010","journal-title":"Oxid Med Cell Longev"},{"key":"32","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.phrs.2011.11.001","article-title":"Beneficial effects of metformin and irbesartan on advanced glycation end products (AGEs)-RAGE-induced proximal tubular cell injury.","volume":"6","author":"Yamagishi","year":"2012","journal-title":"Pharmacol Res"},{"key":"33","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1055\/s-0032-1321878","article-title":"Metformin inhibits advanced glycation end products (AGEs)-induced renal tubular cell injury by suppressing reactive oxygen species generation via reducing receptor for AGEs (RAGE) expression.","volume":"4","author":"Yamagishi","year":"2012","journal-title":"Horm Metab Res"},{"key":"34","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.bbrc.2010.01.119","article-title":"Metformin induces suppression of NAD(P)H oxidase activity in podocytes.","volume":"39","author":"Angielski","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"35","doi-asserted-by":"publisher","first-page":"F686","DOI":"10.1152\/ajprenal.00148.2012","article-title":"AMP-activated protein kinase inhibits TGF-\u03b2-, angiotensin II-, aldosterone-, high glucose-, and albumin-induced epithelial-mesenchymal transition.","volume":"30","author":"Lee","year":"2013","journal-title":"Am J Physiol Renal Physiol"},{"key":"36","doi-asserted-by":"publisher","first-page":"520","DOI":"10.3892\/mmr.2015.3446","article-title":"Metformin alleviates high glucose-mediated oxidative stress in rat glomerular mesangial cells by modulation of p38 mitogen-activated protein kinase expression in vitro.","volume":"1","author":"Wang","year":"2015","journal-title":"Mol Med Rep"},{"key":"37","doi-asserted-by":"publisher","first-page":"4156075","DOI":"10.1155\/2016\/4156075","article-title":"Metformin Prevents Renal Stone Formation through an Antioxidant Mechanism In Vitro and In Vivo.","volume":"201","author":"Zhang","year":"2016","journal-title":"Oxid Med Cell Longev"},{"key":"38","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/ki.2010.11","article-title":"Metformin prevents experimental gentamicin-induced nephropathy by a mitochondria-dependent pathway.","volume":"7","author":"El-Mir","year":"2010","journal-title":"Kidney Int"},{"key":"39","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1038\/ki.2010.20","article-title":"Amelioration of aminoglycoside nephrotoxicity requires protection of renal mitochondria.","volume":"7","author":"Zorov","year":"2010","journal-title":"Kidney Int"},{"key":"40","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1093\/jb\/mvv020","article-title":"Albumin overload down-regulates integrin-\u03b21 through reactive oxygen species-endoplasmic reticulum stress pathway in podocytes.","volume":"15","author":"Chen","year":"2015","journal-title":"J Biochem"},{"key":"41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3967\/bes2019.001","article-title":"Induction of Endoplasmic Reticulum Stress by Cadmium and Its Regulation on Nrf2 Signaling Pathway in Kidneys of Rats.","volume":"3","author":"Yu","year":"2019","journal-title":"Biomed Environ Sci"},{"key":"42","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.ebiom.2018.10.006","article-title":"Endoplasmic reticulum stress is activated in post-ischemic kidneys to promote chronic kidney disease.","volume":"3","author":"Dong","year":"2018","journal-title":"EBioMedicine"},{"key":"43","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1016\/j.kint.2018.11.035","article-title":"Organelle crosstalk in the kidney.","volume":"9","author":"Inagi","year":"2019","journal-title":"Kidney Int"},{"key":"44","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/nrneph.2017.129","article-title":"Endoplasmic reticulum stress, the unfolded protein response and autophagy in kidney diseases.","volume":"1","author":"Cybulsky","year":"2017","journal-title":"Nat Rev Nephrol"},{"key":"45","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.bbrc.2011.05.034","article-title":"Inhibition of the Unfolded Protein Response by metformin in renal proximal tubular epithelial cells.","volume":"40","author":"Pittman","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"46","doi-asserted-by":"publisher","first-page":"e38","DOI":"10.1159\/000342802","article-title":"Activation of AMP-activated protein kinase inhibits albumin-induced endoplasmic reticulum stress and apoptosis through inhibition of reactive oxygen species.","volume":"12","author":"Lee","year":"2012","journal-title":"Nephron, Exp Nephrol"},{"key":"47","doi-asserted-by":"publisher","first-page":"3652","DOI":"10.1002\/jcp.25838","article-title":"Metformin attenuates albumin-induced alterations in renal tubular cells in vitro.","volume":"23","author":"Munusamy","year":"2017","journal-title":"J Cell Physiol"},{"key":"48","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.cellsig.2017.09.020","article-title":"Metformin triggers apoptosis in PEL cells and alters bortezomib-induced Unfolded Protein Response increasing its cytotoxicity and inhibiting KSHV lytic cycle activation.","volume":"4","author":"Cirone","year":"2017","journal-title":"Cell Signal"},{"key":"49","doi-asserted-by":"publisher","first-page":"e14141","DOI":"10.14814\/phy2.14141","article-title":"Metformin modulates immune cell infiltration into the kidney during unilateral ureteral obstruction in mice.","volume":"7","author":"N\u00f8rregaard","year":"2019","journal-title":"Physiol Rep"},{"key":"50","doi-asserted-by":"publisher","first-page":"35952","DOI":"10.1038\/srep35952","article-title":"Renoprotective Effects of Metformin are Independent of Organic Cation Transporters 1 &2 and AMP-activated Protein Kinase in the Kidney.","volume":"6","author":"N\u00f8rregaard","year":"2016","journal-title":"Sci Rep"},{"key":"51","doi-asserted-by":"publisher","first-page":"4847812","DOI":"10.1155\/2016\/4847812","article-title":"Metformin Inhibits Advanced Glycation End Products-Induced Inflammatory Response in Murine Macrophages Partly through AMPK Activation and RAGE\/NFB Pathway Suppression.","volume":"201","author":"Shen","year":"2016","journal-title":"J Diabetes Res"},{"key":"52","first-page":"1755","article-title":"Metformin inhibits nuclear factor-\u03baB activation and inflammatory cytokines expression induced by high glucose via adenosine monophosphate-activated protein kinase activation in rat glomerular mesangial cells in vitro.","volume":"12","author":"Hu","year":"2014","journal-title":"Chin Med J (Engl)"},{"key":"53","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s40620-016-0278-5","article-title":"Lipotoxicity as a trigger factor of renal disease.","volume":"2","author":"Medina-G\u00f3mez","year":"2016","journal-title":"J Nephrol"},{"key":"54","first-page":"170","article-title":"[Effect of fenofibrate and metformin on lipotoxicity in OLETF rat kidney].","volume":"3","author":"Xu","year":"2006","journal-title":"Beijing Da Xue Xue Bao Yi Xue Ban"},{"key":"55","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12263-016-0518-4","article-title":"Comparative anti-inflammatory and lipid-normalizing effects of metformin and omega-3 fatty acids through modulation of transcription factors in diabetic rats.","volume":"1","author":"Kuvalekar","year":"2016","journal-title":"Genes Nutr"},{"key":"56","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.abb.2015.08.009","article-title":"Metformin ameliorates lipotoxicity-induced mesangial cell apoptosis partly via upregulation of glucagon like peptide-1 receptor (GLP-1R).","volume":"58","author":"Park","year":"2015","journal-title":"Arch Biochem Biophys"},{"key":"57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.21873\/invivo.11019","article-title":"Pathophysiological Mechanisms of Renal Fibrosis: A Review of Animal Models and Therapeutic Strategies.","volume":"3","author":"Oliveira","year":"2017","journal-title":"In Vivo"},{"key":"58","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrneph.2016.48","article-title":"TGF-\u03b2: the master regulator of fibrosis.","volume":"1","author":"Lan","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"59","doi-asserted-by":"publisher","first-page":"7045","DOI":"10.1002\/jcp.26505","article-title":"Metformin attenuates folic-acid induced renal fibrosis in mice.","volume":"23","author":"Chen","year":"2018","journal-title":"J Cell Physiol"},{"key":"60","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1111\/1440-1681.12748","article-title":"Metformin attenuates renal fibrosis in both AMPK\u03b12-dependent and independent manners.","volume":"4","author":"Xiao","year":"2017","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"61","doi-asserted-by":"publisher","first-page":"28597","DOI":"10.1038\/srep28597","article-title":"Metformin is a novel suppressor for transforming growth factor (TGF)-\u03b21.","volume":"6","author":"Zhang","year":"2016","journal-title":"Sci Rep"},{"key":"62","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1007\/s10157-013-0781-0","article-title":"Role of the endothelial-to-mesenchymal transition in renal fibrosis of chronic kidney disease.","volume":"1","author":"Kanasaki","year":"2013","journal-title":"Clin Exp Nephrol"},{"key":"63","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1681\/ASN.2013101137","article-title":"Curtailing endothelial TGF-\u03b2 signaling is sufficient to reduce endothelial-mesenchymal transition and fibrosis in CKD.","volume":"2","author":"Goligorsky","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"64","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.ceb.2009.01.021","article-title":"Mechanism of TGF-beta signaling to growth arrest, apoptosis, and epithelial-mesenchymal transition.","volume":"2","author":"Moustakas","year":"2009","journal-title":"Curr Opin Cell Biol"},{"key":"65","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1016\/j.ajpath.2015.04.014","article-title":"Activation of AMP-activated protein kinase prevents TGF-\u03b21-induced epithelial-mesenchymal transition and myofibroblast activation.","volume":"18","author":"Abboud","year":"2015","journal-title":"Am J Pathol"},{"key":"66","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1083\/jcb.126.4.1079","article-title":"Production of hydrogen peroxide by transforming growth factor-beta 1 and its involvement in induction of egr-1 in mouse osteoblastic cells.","volume":"12","author":"Nose","year":"1994","journal-title":"J Cell Biol"},{"key":"67","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1159\/000362249","article-title":"Egr-1 mediates chronic hypoxia-induced renal interstitial fibrosis via the PKC\/ERK pathway.","volume":"3","author":"Wang","year":"2014","journal-title":"Am J Nephrol"},{"key":"68","doi-asserted-by":"publisher","first-page":"1031367","DOI":"10.1155\/2018\/1031367","article-title":"Metformin Improves Epithelial-to-Mesenchymal Transition Induced by TGF-1 in Renal Tubular Epithelial NRK-52E Cells via Inhibiting Egr-1.","volume":"201","author":"Xue","year":"2018","journal-title":"J Diabetes Res"},{"key":"69","doi-asserted-by":"publisher","first-page":"6462793","DOI":"10.1155\/2018\/6462793","article-title":"Metformin Regulating miR-34a Pathway to Inhibit Egr1 in Rat Mesangial Cells Cultured with High Glucose.","volume":"201","author":"Wang","year":"2018","journal-title":"Int J Endocrinol"},{"key":"70","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/nm.3762","article-title":"Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development.","volume":"2","author":"Susztak","year":"2015","journal-title":"Nat Med"},{"key":"71","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1681\/ASN.2018010050","article-title":"Phosphorylation of Acetyl-CoA Carboxylase by AMPK Reduces Renal Fibrosis and Is Essential for the Anti-Fibrotic Effect of Metformin.","volume":"2","author":"Power","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"72","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/ki.2010.112","article-title":"The sweet side of HIF.","volume":"7","author":"Haase","year":"2010","journal-title":"Kidney Int"},{"key":"73","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.2337\/db15-0519","article-title":"HIF-1 Mediates Renal Fibrosis in OVE26 Type 1 Diabetic Mice.","volume":"6","author":"Block","year":"2016","journal-title":"Diabetes"},{"key":"74","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/ki.2010.99","article-title":"High glucose activates HIF-1-mediated signal transduction in glomerular mesangial cells through a carbohydrate response element binding protein.","volume":"7","author":"Haneda","year":"2010","journal-title":"Kidney Int"},{"key":"75","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1161\/HYPERTENSIONAHA.115.05578","article-title":"Elevated Endothelial Hypoxia-Inducible Factor-1\u03b1 Contributes to Glomerular Injury and Promotes Hypertensive Chronic Kidney Disease.","volume":"6","author":"Xia","year":"2015","journal-title":"Hypertension"},{"key":"76","doi-asserted-by":"publisher","first-page":"15878","DOI":"10.1038\/s41598-017-15972-8","article-title":"Hypoxia inducible factor-1\u03b1 mediates the profibrotic effect of albumin in renal tubular cells.","volume":"7","author":"Li","year":"2017","journal-title":"Sci Rep"},{"key":"77","doi-asserted-by":"publisher","first-page":"3810","DOI":"10.1172\/JCI30487","article-title":"Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition.","volume":"11","author":"Haase","year":"2007","journal-title":"J Clin Invest"},{"key":"78","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.kint.2016.05.026","article-title":"Hypoxia-inducible factor-1\u03b1 promotes glomerulosclerosis and regulates COL1A2 expression through interactions with Smad3.","volume":"9","author":"Schnaper","year":"2016","journal-title":"Kidney Int"},{"key":"79","doi-asserted-by":"publisher","first-page":"981","DOI":"10.2337\/db10-0655","article-title":"Tubular injury in a rat model of type 2 diabetes is prevented by metformin: a possible role of HIF-1\u03b1 expression and oxygen metabolism.","volume":"6","author":"Haneda","year":"2011","journal-title":"Diabetes"},{"key":"80","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jphs.2017.12.004","article-title":"Role of hypoxia-inducible factor-1 in the development of renal fibrosis in mouse obstructed kidney: special references to HIF-1 dependent gene expression of profibrogenic molecules.","volume":"13","author":"Miura","year":"2018","journal-title":"J Pharmacol Sci"},{"key":"81","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1007\/s10916-019-1412-4","article-title":"Basic Research in Diabetic Nephropathy Health Care: A study of the Renoprotective Mechanism of Metformin.","volume":"4","author":"Xing","year":"2019","journal-title":"J Med Syst"},{"key":"82","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.exger.2013.12.016","article-title":"AMPK-mediated downregulation of connexin43 and premature senescence of mesangial cells under high-glucose conditions.","volume":"5","author":"Chen","year":"2014","journal-title":"Exp Gerontol"},{"key":"83","doi-asserted-by":"publisher","first-page":"16109","DOI":"10.18632\/oncotarget.14884","article-title":"Alleviation of senescence and epithelial-mesenchymal transition in aging kidney by short-term caloric restriction and caloric restriction mimetics via modulation of AMPK\/mTOR signaling.","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"key":"84","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/d41586-019-02638-w","article-title":"First hint that body\u2019s \u2018biological age\u2019 can be reversed.","volume":"57","author":"Abbott","year":"2019","journal-title":"Nature"},{"key":"85","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/dom.12854","article-title":"Understanding and overcoming metformin gastrointestinal intolerance.","volume":"1","author":"Scheen","year":"2017","journal-title":"Diabetes Obes Metab"},{"key":"86","doi-asserted-by":"publisher","first-page":"20435","DOI":"10.1074\/jbc.M114.567271","article-title":"Low concentrations of metformin suppress glucose production in hepatocytes through AMP-activated protein kinase (AMPK).","volume":"28","author":"He","year":"2014","journal-title":"J Biol Chem"},{"key":"87","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/nature13270","article-title":"Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase.","volume":"51","author":"Lee","year":"2014","journal-title":"Nature"},{"key":"88","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1038\/s41591-018-0125-4","article-title":"Metformin inhibits gluconeogenesis via a redox-dependent mechanism in vivo.","volume":"2","author":"Vatner","year":"2018","journal-title":"Nat Med"},{"key":"89","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.metabol.2015.10.014","article-title":"Metformin-associated lactic acidosis: current perspectives on causes and risk.","volume":"6","author":"Bicsak","year":"2016","journal-title":"Metabolism"},{"key":"90","doi-asserted-by":"publisher","first-page":"2668","DOI":"10.1001\/jama.2014.15298","article-title":"Metformin in patients with type 2 diabetes and kidney disease: a systematic review.","volume":"31","author":"McGuire","year":"2014","journal-title":"JAMA"},{"key":"91","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1002\/pds.3689","article-title":"Mortality rate in so-called \u201cmetformin-associated lactic acidosis\u201d: a review of the data since the 1960s.","volume":"2","author":"Lalau","year":"2014","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"92","doi-asserted-by":"publisher","first-page":"244","DOI":"10.2337\/dc19-0923","article-title":"Reports of Lactic Acidosis Attributed to Metformin, 2015-2018.","volume":"4","author":"Inzucchi","year":"2020","journal-title":"Diabetes Care"},{"key":"93","unstructured":"FDA revises warnings regarding use of the diabetes medicine metformin in certain patients with reduced kidney function. US Food and Drug Administration. https:\/\/www.fda.gov\/drugs\/fda-drug-safety-podcasts\/fda-drug-safety-podcast-fda-revises-warnings-regarding-use-diabetes-medicine-metformin-certain."},{"key":"94","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/S0140-6736(11)61454-2","article-title":"Acute kidney injury.","volume":"38","author":"Ronco","year":"2012","journal-title":"Lancet"},{"key":"95","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/S0140-6736(16)32064-5","article-title":"Chronic Kidney Disease.","volume":"38","author":"Masson","year":"2017","journal-title":"Lancet"},{"key":"96","doi-asserted-by":"publisher","first-page":"F727","DOI":"10.1152\/ajprenal.00293.2013","article-title":"Induction of AMPK activity corrects early pathophysiological alterations in the subtotal nephrectomy model of chronic kidney disease.","volume":"30","author":"Deng","year":"2013","journal-title":"Am J Physiol Renal Physiol"},{"key":"97","doi-asserted-by":"publisher","first-page":"191","DOI":"10.7326\/M16-1901","article-title":"Clinical Outcomes of Metformin Use in Populations With Chronic Kidney Disease, Congestive Heart Failure, or Chronic Liver Disease: A Systematic Review.","volume":"16","author":"Williams","year":"2017","journal-title":"Ann Intern Med"},{"key":"98","doi-asserted-by":"publisher","first-page":"547","DOI":"10.2337\/dc17-2231","article-title":"Metformin Treatment in Patients With Type 2 Diabetes and Chronic Kidney Disease Stages 3A, 3B, or 4.","volume":"4","author":"De Broe","year":"2018","journal-title":"Diabetes Care"},{"key":"99","doi-asserted-by":"publisher","first-page":"37503","DOI":"10.1074\/jbc.M110.136796","article-title":"AMP-activated protein kinase (AMPK) negatively regulates Nox4-dependent activation of p53 and epithelial cell apoptosis in diabetes.","volume":"28","author":"Abboud","year":"2010","journal-title":"J Biol Chem"},{"key":"100","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1152\/physrev.00063.2017","article-title":"Mechanisms of Insulin Action and Insulin Resistance.","volume":"9","author":"Shulman","year":"2018","journal-title":"Physiol Rev"},{"key":"101","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.cmet.2010.08.015","article-title":"Insulin signaling to the glomerular podocyte is critical for normal kidney function.","volume":"1","author":"Pavenst\u00e4dt","year":"2010","journal-title":"Cell Metab"},{"key":"102","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s00109-019-01743-7","article-title":"Role of sirtuin-1 in diabetic nephropathy.","volume":"9","author":"Cai","year":"2019","journal-title":"J Mol Med (Berl)"},{"key":"103","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.bbadis.2017.10.014","article-title":"Metformin overcomes high glucose-induced insulin resistance of podocytes by pleiotropic effects on SIRT1 and AMPK.","volume":"186","author":"Piwkowska","year":"2018","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"104","doi-asserted-by":"publisher","first-page":"e3091","DOI":"10.1002\/dmrr.3091","article-title":"Metformin attenuates renal medullary hypoxia in diabetic nephropathy through inhibition uncoupling protein-2.","volume":"3","author":"Palm","year":"2019","journal-title":"Diabetes Metab Res Rev"},{"key":"105","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1002\/pds.3432","article-title":"Kidney function decline in metformin versus sulfonylurea initiators: assessment of time-dependent contribution of weight, blood pressure, and glycemic control.","volume":"2","author":"Griffin","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"106","doi-asserted-by":"publisher","first-page":"i1450","DOI":"10.1136\/bmj.i1450","article-title":"Diabetes treatments and risk of amputation, blindness, severe kidney failure, hyperglycaemia, and hypoglycaemia: open cohort study in primary care.","volume":"35","author":"Coupland","year":"2016","journal-title":"BMJ"},{"key":"107","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/S0140-6736(18)32782-X","article-title":"Autosomal dominant polycystic kidney disease.","volume":"39","author":"Perrone","year":"2019","journal-title":"Lancet"},{"key":"108","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/s41581-018-0051-1","article-title":"Metabolism and mitochondria in polycystic kidney disease research and therapy.","volume":"1","author":"Caplan","year":"2018","journal-title":"Nat Rev Nephrol"},{"key":"109","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/nm.3092","article-title":"Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy.","volume":"1","author":"Boletta","year":"2013","journal-title":"Nat Med"},{"key":"110","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1073\/pnas.1011498108","article-title":"Activating AMP-activated protein kinase (AMPK) slows renal cystogenesis.","volume":"10","author":"Caplan","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"111","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/s41420-019-0156-8","article-title":"Low-dose 2-deoxyglucose and metformin synergically inhibit proliferation of human polycystic kidney cells by modulating glucose metabolism.","volume":"5","author":"Bai","year":"2019","journal-title":"Cell Death Discov"},{"key":"112","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1111\/bph.14558","article-title":"The combination of metformin and 2-deoxyglucose significantly inhibits cyst formation in miniature pigs with polycystic kidney disease.","volume":"17","author":"Bai","year":"2019","journal-title":"Br J Pharmacol"},{"key":"113","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1186\/s12882-018-1090-3","article-title":"Metformin in autosomal dominant polycystic kidney disease: experimental hypothesis or clinical fact?","volume":"1","author":"Sabbatini","year":"2018","journal-title":"BMC Nephrol"},{"key":"114","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1007\/s10157-019-01770-1","article-title":"ADPKD and metformin: from bench to bedside.","volume":"2","author":"Pisani","year":"2019","journal-title":"Clin Exp Nephrol"},{"key":"115","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.ebiom.2019.08.041","article-title":"Salsalate, but not metformin or canagliflozin, slows kidney cyst growth in an adult-onset mouse model of polycystic kidney disease.","volume":"4","author":"Pei","year":"2019","journal-title":"EBioMedicine"},{"key":"116","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.4049\/jimmunol.1403088","article-title":"Metformin Suppresses Systemic Autoimmunity in Mice through Inhibiting B Cell Differentiation into Plasma Cells via Regulation of AMPK\/mTOR\/STAT3.","volume":"19","author":"Cho","year":"2017","journal-title":"J Immunol"},{"key":"117","doi-asserted-by":"publisher","first-page":"3190","DOI":"10.1002\/art.39296","article-title":"Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin.","volume":"6","author":"Ye","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"118","doi-asserted-by":"publisher","first-page":"274ra18","DOI":"10.1126\/scitranslmed.aaa0835","article-title":"Normalization of CD4+ T cell metabolism reverses lupus.","volume":"7","author":"Morel","year":"2015","journal-title":"Sci Transl Med"},{"key":"119","unstructured":"Sachdeva, Jana, Curti. Renal Cell Carcinoma. Medscape. 2014. https:\/\/emedicine.medscape.com\/article\/281340-overview#showall."},{"key":"120","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrclinonc.2016.60","article-title":"Cancer metabolism: a therapeutic perspective.","volume":"1","author":"Lisanti","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"key":"121","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.ctrv.2015.07.002","article-title":"Metabolic alterations in renal cell carcinoma.","volume":"4","author":"Tortora","year":"2015","journal-title":"Cancer Treat Rev"},{"key":"122","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.3892\/ol.2018.8832","article-title":"Metformin-induced apoptosis facilitates degradation of the cellular caspase 8 (FLICE)-like inhibitory protein through a caspase-dependent pathway in human renal cell carcinoma A498 cells.","volume":"1","author":"Kim","year":"2018","journal-title":"Oncol Lett"},{"key":"123","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.urolonc.2011.01.003","article-title":"Metformin inhibits renal cell carcinoma in vitro and in vivo xenograft.","volume":"3","author":"Hu","year":"2013","journal-title":"Urol Oncol"},{"key":"124","doi-asserted-by":"publisher","first-page":"29","DOI":"10.12659\/MSM.898710","article-title":"Metformin Induces Growth Inhibition and Cell Cycle Arrest by Upregulating MicroRNA34a in Renal Cancer Cells.","volume":"2","author":"Zhang","year":"2017","journal-title":"Med Sci Monit"},{"key":"125","first-page":"3289","article-title":"Metformin inhibits cell growth by upregulating microRNA-26a in renal cancer cells.","volume":"7","author":"Zheng","year":"2014","journal-title":"Int J Clin Exp Med"},{"key":"126","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1159\/000441011","article-title":"Metformin-Derived Growth Inhibition in Renal Cell Carcinoma Depends on miR-21-Mediated PTEN Expression.","volume":"9","author":"Vergho","year":"2016","journal-title":"Urol Int"},{"key":"127","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3390\/biom9030113","article-title":"Metformin Induces Different Responses in Clear Cell Renal Cell Carcinoma Caki Cell Lines.","volume":"9","author":"Munusamy","year":"2019","journal-title":"Biomolecules"},{"key":"128","doi-asserted-by":"publisher","first-page":"617","DOI":"10.7150\/ijbs.29689","article-title":"Activation of AMPK by metformin promotes renal cancer cell proliferation under glucose deprivation through its interaction with PKM2.","volume":"1","author":"Jin","year":"2019","journal-title":"Int J Biol Sci"},{"key":"129","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1007\/s11255-017-1548-4","article-title":"The impact of metformin use on survival in kidney cancer patients with diabetes: a meta-analysis.","volume":"4","author":"Mi","year":"2017","journal-title":"Int Urol Nephrol"},{"key":"130","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.clgc.2015.12.012","article-title":"Metformin Use in Relation With Survival Outcomes of Patients With Renal Cell Carcinoma.","volume":"1","author":"Tan","year":"2016","journal-title":"Clin Genitourin Cancer"},{"key":"131","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.clgc.2016.06.008","article-title":"Metformin Use and Kidney Cancer Outcomes in Patients With Diabetes: A Propensity Score Analysis.","volume":"1","author":"Hamilton","year":"2017","journal-title":"Clin Genitourin Cancer"},{"key":"132","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/s41586-019-1005-x","article-title":"Effective breast cancer combination therapy targeting BACH1 and mitochondrial metabolism.","volume":"56","author":"Kang","year":"2019","journal-title":"Nature"},{"key":"133","doi-asserted-by":"publisher","first-page":"e13302","DOI":"10.1111\/ctr.13302","article-title":"Metformin use in the first year after kidney transplant, correlates, and associated outcomes in diabetic transplant recipients: A retrospective analysis of integrated registry and pharmacy claims data.","volume":"3","author":"Lentine","year":"2018","journal-title":"Clin Transplant"},{"key":"134","doi-asserted-by":"publisher","first-page":"979","DOI":"10.4158\/EP.14.8.979","article-title":"Effectiveness and long-term safety of thiazolidinediones and metformin in renal transplant recipients.","volume":"1","author":"Helmuth","year":"2008","journal-title":"Endocr Pract"},{"key":"135","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s12882-019-1321-2","article-title":"Transplantation and diabetes (Transdiab): a pilot randomised controlled trial of metformin in impaired glucose tolerance after kidney transplantation.","volume":"2","author":"Pilmore","year":"2019","journal-title":"BMC Nephrol"},{"key":"136","doi-asserted-by":"publisher","first-page":"e016813","DOI":"10.1136\/bmjopen-2017-016813","article-title":"Protocol for a pilot randomised controlled trial of metformin in pre-diabetes after kidney transplantation: the Transplantation and Diabetes (Transdiab) study.","volume":"7","author":"Manley","year":"2017","journal-title":"BMJ Open"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.103095","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T20:20:45Z","timestamp":1599078045000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.103095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,1]]},"references-count":136,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,5,15]]}},"alternative-id":["103095","32364526"],"URL":"https:\/\/doi.org\/10.18632\/aging.103095","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,1]]}}}